Search research articles
Contact Us
Filters
Showing results (131-140 of 138) with videos related to
Page
of 14
Sort By:
You have reached the last page of results.
This site can display upto 138 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2004
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group
S de Botton, A Fawaz, S Chevret, et al.
Leukemia
|
November 27, 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
L Ades, S Chevret, S De Botton, et al.
Bone Marrow Transplantation
|
October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation
G Gahrton, H Svensson, B Björkstrand, et al.
Leukemia
|
April 6, 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma
X Leleu, G Fouquet, B Hebraud, et al.
British Journal of Haematology
|
September 12, 1998
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
E Wattel, E Solary, B Hecquet, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS
E Wattel, E Solary, B Hecquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
Page
of 14
Search research articles
Search
Showing results (131-140 of 138) with videos related to
Sort By:
Page
of 14
You have reached the last page of results.
This site can display upto 138 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2004
Autologous and allogeneic stem-cell transplantation as salvage treatment of acute promyelocytic leukemia initially treated with all-trans-retinoic acid: a retrospective analysis of the European acute promyelocytic leukemia group
S de Botton, A Fawaz, S Chevret, et al.
Leukemia
|
November 27, 2004
Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience
L Ades, S Chevret, S De Botton, et al.
Bone Marrow Transplantation
|
October 12, 1999
Syngeneic transplantation in multiple myeloma - a case-matched comparison with autologous and allogeneic transplantation. European Group for Blood and Marrow Transplantation
G Gahrton, H Svensson, B Björkstrand, et al.
Leukemia
|
April 6, 2013
Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma
X Leleu, G Fouquet, B Hebraud, et al.
British Journal of Haematology
|
September 12, 1998
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
E Wattel, E Solary, B Hecquet, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS
E Wattel, E Solary, B Hecquet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2016
Safe and prolonged survival with long-term exposure to pomalidomide in relapsed/refractory myeloma
G Fouquet, B Pegourie, M Macro, et al.
Leukemia
|
July 30, 2013
Deletion of the 1p32 region is a major independent prognostic factor in young patients with myeloma: the IFM experience on 1195 patients
B Hebraud, X Leleu, V Lauwers-Cances, et al.
Page
of 14